Breaking News
1. US strikes Iran’s nuclear sites: Vice President JD Vance says war is with weapons programme, not people      2. '2,200km Away': Israel strikes Khorramshahr missile storage facilities in Iran for first time      3. "Why Wouldn't There Be Regime Change?" Trump's 'MIGA' Message For Iran      4. Iran moves to block Strait of Hormuz: What this will mean for India, Tehran, world, in 4 points      5. Satellite Images Question Trump's Claim Iran's Atomic Sites Destroyed      6. Netanyahu's First Remark After US Bombs Iran Nuclear Sites      7. Operation Sindhu: Nepal thanks India for Iran evacuation      8. Israel kills three Iranian military chiefs, hits nuclear sites in fresh air strikes.      9. US Bombers Flew 37 Hours Non-Stop, Refuelled Mid-Air To Hit Iran Nuclear Sites      10. Iranians killed, UN warns of refugee crisis; Tel Aviv strikes Isfahan nuclear plant for 2nd time      11. Provided food, shelter': 2 held for harbouring Pahalgam attack terrorists; disclose 3 were Pak LeT men      12. Iran, Israel Launch Fresh Attacks As Tehran Rules Out Nuclear Talks      13. Israel-Iran war: Donald Trump counters Tulsi Gabbard on Iran's nuclear programme; says 'my intelligence community was wrong'      14. Pak nominates Trump for Nobel Prize for 'pivotal leadership' in truce with India      15. Trump indicates he’s disinclined to restrain Israel ‘when it’s winning’ against Iran      16. PM Modi leads 11th International Yoga Day celebrations from Visakhapatnam      17. Missile strike on hospital to calls for Khamenei's elimination      18. ‘Saw missiles and drones’: Indian students evacuated from Iran arrive in Delhi, hail support from embassy      19. Air India warned for flying Airbus planes with unchecked escape slides      20. Donald Trump to decide on US role in Iran-Israel conflict within two weeks, says White House     

AI Chatbots Like ChatGPT Show Promise in Evidence-Based Depression Care

  • Posted on October 18, 2023
  • Technology
  • By Arijit Dutta
  • 389 Views

A groundbreaking study published in the open-access journal Family Medicine and Community Health suggests that ChatGPT, OpenAI's AI chatbot, could surpass primary care doctors in evidence-based depression management. This research delves into the capabilities of ChatGPT, unveiling its potential to provide objective and data-driven insights for clinical depression while sidestepping biases present in doctor-patient relationships.

AI Chatbots Like ChatGPT Show Promise in Evidence-Based Depression Care Image Source -www.siasat.com

A groundbreaking study published in the open-access journal Family Medicine and Community Health suggests that ChatGPT, OpenAI's AI chatbot, could surpass primary care doctors in evidence-based depression management. This research delves into the capabilities of ChatGPT, unveiling its potential to provide objective and data-driven insights for clinical depression while sidestepping biases present in doctor-patient relationships.

The study focused on assessing ChatGPT's ability to recommend treatment approaches for both mild and severe major depression, with a specific eye on biases related to gender and social class. When questioned about primary care physician recommendations, ChatGPT offered a range of suggestions, including "watchful waiting," "referral for psychotherapy," "prescribed drugs for depression, anxiety, or sleep problems," and "referral for psychotherapy combined with prescribed drugs."

In a remarkable revelation, the research found that ChatGPT-3.5 and ChatGPT-4 recommended psychotherapy referral in 95% and 97.5% of cases for mild depression, far exceeding the 4% suggested by family doctors, aligning closely with clinical guidelines. Doctors, on the other hand, leaned towards prescribing drugs alone (48%) or a combination of psychotherapy and drugs (32.5%). In severe cases, doctors predominantly advised psychotherapy coupled with prescribed drugs (44.5%).

In the realm of severe depression, ChatGPT outshone doctors yet again, advocating for treatment alignment with clinical guidelines more frequently – 100% for ChatGPT-4. A notable contrast was the 40% of doctors who exclusively recommended drug treatment, a deviation from ChatGPT's approach.

Moreover, doctors frequently proposed a blend of antidepressants, anti-anxiety medications, and sleeping pills in 67.5% of cases, while ChatGPT leaned more towards recommending antidepressants alone, with 74% for ChatGPT-3.5 and 68% for ChatGPT-4. ChatGPT-3.5 (26%) and ChatGPT-4 (32%) also suggested a combination of these medications.

Also Read: DS Group's Strategic Expansion: Prospects Of A ₹2,000 Crore Deal With Great India Place Mall

The study's key takeaway was the precision and unbiased nature of ChatGPT-4's treatment alignment with clinical guidelines. No discernible biases related to gender or socioeconomic status were detected in the ChatGPT systems, signifying their potential to enhance decision-making in primary healthcare.

In short, this research underlines the potential of AI chatbots, such as ChatGPT, to serve as valuable tools for healthcare professionals by offering evidence-based and unbiased treatment recommendations for clinical depression. This development has the potential to elevate the standard of care for patients suffering from depression and represents a significant stride in the realm of technology-assisted healthcare.

Author
No Image
Author
Arijit Dutta

You May Also Like